Observational Registry Study of Renal Transplant Patients
NCT01284257 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2017-02-27
Summary
The MORE Observational Study follows real-world renal transplant patients with the data resolution of a monitored, prospective clinical trial for 5 years. In addition to capturing detailed clinical data, the study describes recent important changes in surveillance testing and drug therapy and relates these changes to short and long-term outcomes. Also, the study measures patient compliance over time and details the rationale for modifications of MPA dosing in maintenance and regimen changes after episodes of AR. The MORE study will provide information on era changes in transplant practices and their impact on clinical outcome, new insights on optimizing regimens for discrete patient subsets and new perspectives on the optimal use of MPA therapy.
Conditions
- Kidney Transplant
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2010-05-31
- Completion
- 2010-05-31
Countries
- United States
Study Locations
More Related Trials
-
24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients
NCT00555789 ·Status: TERMINATED ·Phase: PHASE2
-
Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation
NCT00203671 ·Status: COMPLETED
-
Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
NCT01950819 ·Status: COMPLETED ·Phase: PHASE4
-
Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation
NCT00166244 ·Status: COMPLETED ·Phase: PHASE4
-
Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients
NCT00369278 ·Status: COMPLETED ·Phase: PHASE3
-
mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation
NCT01028092 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant
NCT00446251 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients
NCT00780429 ·Status: UNKNOWN
-
RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
NCT03797196 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant
NCT00200551 ·Status: COMPLETED ·Phase: PHASE4
-
The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.
NCT00275522 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus
NCT00171392 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients
NCT00239018 ·Status: COMPLETED ·Phase: PHASE4
-
Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation
NCT03968588 ·Status: COMPLETED ·Phase: PHASE4
-
Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients
NCT00241059 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)
NCT01595984 ·Status: UNKNOWN ·Phase: PHASE3
-
Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure
NCT00223678 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients
NCT03221842 ·Status: TERMINATED ·Phase: PHASE3
-
A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients
NCT00862979 ·Status: COMPLETED ·Phase: PHASE4
-
Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen
NCT01560572 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
NCT02334488 ·Status: COMPLETED ·Phase: PHASE3
-
Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk
NCT04473924 ·Status: WITHDRAWN ·Phase: PHASE2
-
Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant
NCT00646737 ·Status: COMPLETED ·Phase: PHASE4
-
MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
NCT06044493 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients
NCT02453867 ·Status: UNKNOWN ·Phase: PHASE4